Abstract:Objectives To evaluate the existing evidence for associations between coffee consumption and multiple health outcomes.Design Umbrella review of the evidence across meta-analyses of observational and interventional studies of coffee consumption and any health outcome.Data sources PubMed, Embase, CINAHL, Cochrane Database of Systematic Reviews, and screening of references.Eligibility criteria for selecting studies Meta-analyses of both observational and interventional studies that examined the associations between coffee consumption and any health outcome in any adult population in all countries and all settings. Studies of genetic polymorphisms for coffee metabolism were excluded.Results The umbrella review identified 201 meta-analyses of observational research with 67 unique health outcomes and 17 meta-analyses of interventional research with nine unique outcomes. Coffee consumption was more often associated with benefit than harm for a range of health outcomes across exposures including high versus low, any versus none, and one extra cup a day. There was evidence of a non-linear association between consumption and some outcomes, with summary estimates indicating largest relative risk reduction at intakes of three to four cups a day versus none, including all cause mortality (relative risk 0.83 (95% confidence interval 0.79 to 0.88), cardiovascular mortality (0.81, 0.72 to 0.90), and cardiovascular disease (0.85, 0.80 to 0.90). High versus low consumption was associated with an 18% lower risk of incident cancer (0.82, 0.74 to 0.89). Consumption was also associated with a lower risk of several specific cancers and neurological, metabolic, and liver conditions. Harmful associations were largely nullified by adequate adjustment for smoking, except in pregnancy, where high versus low/no consumption was associated with low birth weight (odds ratio 1.31, 95% confidence interval 1.03 to 1.67), preterm birth in the first (1.22, 1.00 to 1.49) and second (1.12, 1.02 to 1.22) trimester, and pregnancy loss (1.46, 1.06 to 1.99). There was also an association between coffee drinking and risk of fracture in women but not in men.Conclusion Coffee consumption seems generally safe within usual levels of intake, with summary estimates indicating largest risk reduction for various health outcomes at three to four cups a day, and more likely to benefit health than harm. Robust randomised controlled trials are needed to understand whether the observed associations are causal. Importantly, outside of pregnancy, existing evidence suggests that coffee could be tested as an intervention without significant risk of causing harm. Women at increased risk of fracture should possibly be excluded.

Coffee consumption and coronary calcification: the Rotterdam Coronary Calcification Study

Coffee consumption and associations with blood pressure, LDL-cholesterol and echocardiographic measures in the general population

Coffee Intake and Risk of Diabetic Nephropathy: a Mendelian Randomization Study

Coffee Consumption and Abdominal Aortic Calcification among Adults with and Without Hypertension, Diabetes, and Cardiovascular Diseases.

Association of Coffee Drinking with All-Cause Mortality: A Systematic Review and Meta-Analysis

Significant Impact of Coffee Consumption on MR-Based Measures of Cardiac Function in a Population-Based Cohort Study without Manifest Cardiovascular Disease

Association of Coffee Consumption with All-Cause and Cardiovascular Disease Mortality

Coffee consumption and C-reactive protein levels: a systematic review and meta-analysis

Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes

Association of Coffee Consumption With Overall and Cause-Specific Mortality in a Large US Prospective Cohort Study

Association of Coffee Consumption with Atherosclerotic Cardiovascular Disease and All-Cause Mortality in Adults with Familial Hypercholesterolemia: Results from National Health and Nutrition Examination Survey (NHANES)

Coffee Consumption and Risk of Fractures: a Meta-Analysis

Coffee consumption is associated with a reduced risk of colorectal cancer recurrence and all‐cause mortality

Coffee consumption and risk of bladder cancer: a pooled analysis of 501,604 participants from 12 cohort studies in the BLadder Cancer Epidemiology and Nutritional Determinants (BLEND) international study

The association between coffee and caffeine consumption and renal function: insight from individual-level data, Mendelian randomization, and meta-analysis

The role of coffee and potential mediators in subclinical atherosclerosis: insights from Mendelian randomization study

Association Between Coffee Intake and Incident Heart Failure Risk

Association of coffee intake with bone mineral density: a Mendelian randomization study

Coffee Consumption and Incidence of Cardiovascular and Microvascular Diseases in Never-Smoking Adults with Type 2 Diabetes Mellitus

Metabolites Associated with Coffee Consumption and Incident Chronic Kidney Disease

Association between Coffee and Incident Heart Failure: A Prospective Cohort Study from the UK Biobank